Literature DB >> 2268267

Effect of aluminium on iron uptake and transferrin-receptor expression by human erythroleukaemia K562 cells.

S J McGregor1, M L Naves, R Oria, J K Vass, J H Brock.   

Abstract

Incubation of human erythroleukaemia K562 cells with Al-transferrin inhibited iron uptake from 59Fe-transferrin by about 80%. The inhibition was greater than that produced by a similar quantity of Fe-transferrin. Preincubation of cells for 6 h with either Al-transferrin or Fe-transferrin diminished the number of surface transferrin receptors by about 40% compared with cells preincubated with apo-transferrin. Al-transferrin did not compete significantly with Fe-transferrin for transferrin receptors and, when cells were preincubated for 15 min instead of 6 h, the inhibitory effect of Al-transferrin on receptor expression was lost. Both forms of transferrin also decreased the level of transferrin receptor mRNA by about 50%, suggesting a common regulatory mechanism. Aluminium citrate had no effect on iron uptake or transferrin-receptor expression. AlCl3 also had no effect on transferrin-receptor expression, but at high concentration it caused an increase in iron uptake by an unknown, possibly non-specific, mechanism. Neither Al-transferrin nor AlCl3 caused a significant change in cell proliferation. It is proposed that aluminium, when bound to transferrin, inhibits iron uptake partly by down-regulating transferrin-receptor expression and partly by interfering with intracellular release of iron from transferrin.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2268267      PMCID: PMC1149710          DOI: 10.1042/bj2720377

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  23 in total

1.  The effect of the iron saturation of transferrin on its binding and uptake by rabbit reticulocytes.

Authors:  S P Young; A Bomford; R Williams
Journal:  Biochem J       Date:  1984-04-15       Impact factor: 3.857

2.  Dialysis encephalopathy, bone disease and anaemia: the aluminum intoxication syndrome during regular haemodialysis.

Authors:  I S Parkinson; M K Ward; D N Kerr
Journal:  J Clin Pathol       Date:  1981-11       Impact factor: 3.411

3.  Alzheimer's disease: X-ray spectrometric evidence of aluminum accumulation in neurofibrillary tangle-bearing neurons.

Authors:  D P Perl; A R Brody
Journal:  Science       Date:  1980-04-18       Impact factor: 47.728

4.  The effect of iron and transferrin on the response of serum-free cultures of mouse lymphocytes to concanavalin A and lipopolysaccharide.

Authors:  J H Brock
Journal:  Immunology       Date:  1981-06       Impact factor: 7.397

5.  Approaches to the standardization of serum unsaturated iron-binding capacity.

Authors:  G Grahm; G W Bates
Journal:  J Lab Clin Med       Date:  1976-09

6.  Plasma aluminum is bound to transferrin.

Authors:  G A Trapp
Journal:  Life Sci       Date:  1983-07-25       Impact factor: 5.037

7.  Primary structure of human transferrin receptor deduced from the mRNA sequence.

Authors:  C Schneider; M J Owen; D Banville; J G Williams
Journal:  Nature       Date:  1984 Oct 18-24       Impact factor: 49.962

8.  Interaction of horse-spleen ferritin with aluminium citrate.

Authors:  M Cochran; V Chawtur
Journal:  Clin Chim Acta       Date:  1988-11       Impact factor: 3.786

9.  Aluminum inhibits hemoglobin synthesis but enhances iron uptake in Friend erythroleukemia cells.

Authors:  K Abreo; J Glass; M Sella
Journal:  Kidney Int       Date:  1990-02       Impact factor: 10.612

10.  Regulation of transferrin receptor expression on human leukemic cells during proliferation and induction of differentiation. Effects of gallium and dimethylsulfoxide.

Authors:  C R Chitambar; E J Massey; P A Seligman
Journal:  J Clin Invest       Date:  1983-10       Impact factor: 14.808

View more
  6 in total

1.  The role of transferrin and citrate in cellular uptake of aluminium.

Authors:  S J McGregor; J H Brock; D Halls
Journal:  Biol Met       Date:  1991

Review 2.  Systematic review of potential health risks posed by pharmaceutical, occupational and consumer exposures to metallic and nanoscale aluminum, aluminum oxides, aluminum hydroxide and its soluble salts.

Authors:  Calvin C Willhite; Nataliya A Karyakina; Robert A Yokel; Nagarajkumar Yenugadhati; Thomas M Wisniewski; Ian M F Arnold; Franco Momoli; Daniel Krewski
Journal:  Crit Rev Toxicol       Date:  2014-10       Impact factor: 5.635

3.  Hippocampal tin, aluminum and zinc in Alzheimer's disease.

Authors:  F M Corrigan; G P Reynolds; N I Ward
Journal:  Biometals       Date:  1993       Impact factor: 2.949

4.  An in vitro study on the binding of Al(III) to human serum transferrin with the isoelectric focusing technique.

Authors:  G de Jong; C C Ammerlaan; W L van Noort; H G van Eijk; G L van Landeghem; P C D'Haese; M E de Broe
Journal:  Biometals       Date:  1995-10       Impact factor: 2.949

5.  Heme oxygenase induction. A possible factor in aluminum-associated anemia.

Authors:  B Fulton; E H Jeffery
Journal:  Biol Trace Elem Res       Date:  1994-01       Impact factor: 3.738

Review 6.  The biological speciation and toxicokinetics of aluminum.

Authors:  E DeVoto; R A Yokel
Journal:  Environ Health Perspect       Date:  1994-11       Impact factor: 9.031

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.